• Vardenafil in Proteoform-Resolved PDE5 Research

  2026-08-17

  Vardenafil HCl Trihydrate offers a powerful reference point for connecting PDE5 inhibition, cGMP signaling, smooth muscle relaxation research, and native-membrane proteoform analysis. This article moves beyond conventional potency claims to outline a translational workflow that evaluates isoform selectivity, functional responses, off-target PDE6 interactions, and compound handling in a context-aware manner.

• Tofacitinib Citrate: JAK3 Research Workflows

  2026-08-17

  Tofacitinib citrate supports concentration-aware studies of lymphocyte signaling, cytokine responses, and endothelial inflammation. This guide separates immune pathway inhibition from vascular protection so researchers can select readouts, controls, and doses that answer distinct mechanistic questions.

• Nocodazole and the Logic of Microtubule Perturbation

  2026-08-16

  A translational framework for using Nocodazole as a microtubule polymerization inhibitor to connect microtubule dynamics research, cell cycle regulation assays, pathogen entry studies, and anticancer drug evaluation.

• CTOP for Mechanistic Opioid Pain Research

  2026-08-15

  CTOP is a selective μ-opioid receptor antagonist for separating MOR-dependent signaling from downstream spinal and behavioral effects. This guide translates recent circuit-level findings into practical assay and control strategies for opioid receptor binding studies and pain mechanism research.

• β-Elemene: AMPK Adipogenesis Workflow Guide

  2026-08-14

  Use β-Elemene as a mechanistic probe in adipocyte differentiation, insulin-resistance, lipid-accumulation, and AMPK studies. This guide translates a recent 3T3-L1 workflow into practical dosing, assay-selection, formulation, and troubleshooting decisions while distinguishing metabolic evidence from emerging anticancer and neuroprotective applications.

• Gly-Gly-Phe-Gly (GGFG) for Drug Conjugation

  2026-08-14

  Gly-Gly-Phe-Gly (GGFG) provides a compact, flexible peptide scaffold for controlled drug conjugation, antibody-drug conjugate development, and peptide engineering. This practical guide connects linker selection with assay design, workflow controls, and the ER-stress biology highlighted in a multiple myeloma combination-therapy study.

• Letrozole A1307: Reliable Assay Design

  2026-08-13

  A scenario-based guide to using Letrozole (SKU A1307) in cell viability, proliferation, and endocrine-response assays. It translates the compound’s 11.5 nM aromatase IC50, DMSO solubility, storage requirements, and reversible mechanism into practical experimental decisions.

• CTOP: A μ-Opioid Receptor Antagonist

  2026-08-13

  A translational framework for using CTOP to test μ-opioid receptor causality in opioid-induced mechanical hypersensitivity, tolerance, and brain-to-spinal pain circuits.

• Nicotinamide Riboside Chloride in RGC Models

  2026-08-12

  Nicotinamide Riboside Chloride (NIAGEN) adds a controllable NAD+ metabolism variable to reproducible iPSC-derived retinal ganglion cell workflows. This article shows how to separate lineage-generation effects from metabolic resilience, with practical dosing, controls, and troubleshooting for glaucoma and broader neurodegenerative disease models.

• Mitoxantrone BA2039: Reliable Cell Assays

  2026-08-12

  Learn how Mitoxantrone (SKU BA2039) can support reproducible viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers DMSO formulation, assay controls, dose–response design, ABCG2-mediated resistance, and practical product-selection criteria.

• Biotin (Vitamin B7) for Labeling and STING Assays

  2026-08-11

  Biotin (Vitamin B7) connects metabolic biochemistry with high-sensitivity protein and nucleic-acid detection workflows. This guide shows how to prepare the reagent, avoid chemistry-related artifacts, and adapt biotin-based assays to the emerging shrimp STING antiviral model without overstating what the reference study demonstrated.

• Patient-Derived Gastric Cancer Assembloids

  2026-08-11

  This 2025 study develops a patient-derived gastric cancer assembloid that combines matched tumor organoids with tumor-derived stromal subpopulations. The model captures stromal effects on gene expression and drug sensitivity, offering a more informative framework for resistance analysis and personalized preclinical testing than organoid monocultures alone.

• Mitoxantrone HCl: Designing Mechanistic Assays

  2026-08-10

  Mitoxantrone HCl is more than a DNA topoisomerase II inhibitor: it is a versatile probe for separating DNA damage, receptor destabilization, apoptosis, and immune-cell effects. Learn how to design orthogonal assays that clarify mechanism across cancer and disease models.

• Phosbind Acrylamide for Phosphorylation Analysis

  2026-08-09

  Phosbind Acrylamide enables antibody-free resolution of phosphorylated and non-phosphorylated proteins directly in SDS-PAGE. This workflow is especially useful for testing stress-response signaling, kinase activity, and phosphorylation-dependent mobility changes in targets such as eIF2α.

• Transcription Termination After WEE1 Inhibition

  2026-08-08

  The reference study identifies transcription termination as an active safeguard against replication-associated DNA damage after WEE1 inhibition. Its experiments connect termination-factor loss and transcriptional read-through with S-phase genome instability, while supporting combined targeting of WEE1 and CPSF73 in prostate cancer models.

16421 records 1/1095 page Next 12345 下5页 Last page